Posts by Delta Care Rx
Healthcare Tech Outlook Names Delta Care Rx a Top 10 Pharmacy Management Solution Provider
FREMONT, Calif. /ScoopCloud/ -- Delta Care Rx, a leading pharmaceutical innovator in end of life care, has been named one of the "Top 10 Pharmacy Management Solution Providers of 2018," according to Healthcare Tech Outlook, a digital and print magazine publication of Valley Media, Inc.
Adapt by Delta Care Rx Debuts a Shared Patient-Clinician Palliative Care Experience Powered by TapCloud
PITTSBURGH, Pa. /ScoopCloud/ -- The simple touch of a finger sparks the newest innovation in the quest for quality, responsive patient-centered care. Adapt by Delta Care Rx, an advanced disease management and therapeutics solution, debuts a patient-clinician communication interface powered by TapCloud, a leading provider of real time patient generated health data.
Delta Care Rx Now Interfaces with HEALTHCAREfirst Electronic Health Records
PITTSBURGH, Pa. /ScoopCloud/ -- Delta Care Rx, a leading pharmaceutical innovator in end of life care, announces an exciting interface with HEALTHCAREfirst, a leading provider of web-based home health and hospice software, billing and coding services, Consumer Assessment of Healthcare Providers and Systems, or CAHPS, Surveys and advanced analytics.
Delta Care Rx Now Integrates with Suncoast Electronic Medical Records
PITTSBURGH, Pa. /ScoopCloud/ -- Delta Care Rx, a leading pharmaceutical innovator in end of life care, announces a robust integration with Suncoast by Complia Health, a leading global provider of home health care and hospice software solutions.
Delta Care Rx Announces Patrick White, MD, Inaugural Recipient of Delta Distinguished Scholar Award
PITTSBURGH, Pa. /ScoopCloud/ -- Delta Care Rx today announced the first-ever recipient of the Delta Distinguished Scholar award. Patrick White, MD, HMDC, FACP, FAAHPM, chief medical officer of BJC Hospice, St. Louis, and assistant professor of medicine at Washington University, has received an initial $25,000 research grant, with a $500,000 lifetime potential, for study into the comparative and cost effectiveness of pharmaceuticals.